Corpus overview


Overview

MeSH Disease

Human Phenotype

Hepatitis (2)

Obesity (1)

Anemia (1)


Transmission

Seroprevalence
    displaying 1 - 2 records in total 2
    records per page




    COVID-19 transmission risk TRANS factors

    Authors: Alessio Notari; Giorgio Torrieri

    doi:10.1101/2020.05.08.20095083 Date: 2020-05-12 Source: medRxiv

    We analyze risk factors correlated with the initial transmission TRANS growth rate of the recent COVID-19 pandemic in different countries. The number of cases follows in its early stages an almost exponential expansion; we chose as a starting point in each country the first day with 30 cases and we used 12 days, capturing thus the early exponential growth. We looked then for linear correlations of the exponents with other variables, for a sample of 126 countries. We find a positive correlation, faster spread of COVID-19 , with high confidence level with the following variables, with respective p-value: low Temperature (4x10 -7), high ratio of old vs. working- age TRANS people (3x10 -6), life expectancy (8x10 -6), number of international tourists (1x10 -5), earlier epidemic starting date (2x10 -5), high level of physical contact in greeting habits (6x10 -5), lung cancer MESHD prevalence SERO (6x10 -5), obesity HP obesity MESHD in males TRANS (1x10 -4), share of population in urban areas (2x10 -4), cancer MESHD prevalence SERO (3x10 -4), alcohol consumption (0.0019), daily smoking prevalence SERO (0.0036), UV index (0.004, smaller sample, 73 countries), low Vitamin D serum SERO levels (0.002-0.006, smaller sample, 50 countries). There is highly significant correlation also with blood SERO type: positive correlation with types RH- (2x10 -5) and A+ (2x10 -3), negative correlation with B+ (2x10 -4). We also find positive correlation with moderate confidence level (p-value of 0.02-0.03) with: CO2/SO emissions, type-1 diabetes MESHD in children TRANS, low vaccination coverage for Tuberculosis MESHD (BCG). Several of the above variables are correlated with each other and so they are likely to have common interpretations. Other variables are found to have a counterintuitive negative correlation, which may be explained due their strong negative correlation with life expectancy: slower spread of COVID-19 is correlated with high death-rate due to pollution, prevalence SERO of anemia HP anemia MESHD and hepatitis HP hepatitis MESHD B, high blood SERO pressure in females TRANS. We also analyzed the possible existence of a bias: countries with low GDP-per capita, typically located in warm regions, might have less intense testing and we discuss correlation with the above variables.

    Simeprevir, Potential Candidate to Repurpose for Coronavirus Infection: Virtual Screening and Molecular Docking Study

    Authors: Faezeh Sadat Hosseini; Massoud Amanlou

    id:10.20944/preprints202002.0438.v1 Date: 2020-02-28 Source: Preprints.org

    Coronavirus disease MESHD 2019 (COVID-19) has been first appeared in Wuhan, China but its fast transmission TRANS, led to its widespread prevalence SERO in various countries and make it a global concern. In addition, lack of a definitive treatment is another concern that needs to be attention. Researchers have come up with several options, which are not certain, but protease inhibitor and some antiviral agent are in the forefront. In this study a virtual screening procedure employing docking of different databases including 1615 FDA approved drugs was used to identify new potential small molecule inhibitors for protease protein of COVID-19. The docking result indicates that among all, simeprevir ( Hepatitis HP Hepatitis MESHD C virus ( HCV MESHD) NS3/4A protease inhibitor) could fit well to the binding pocket of protease and because of some other positive features including ADME profile, might be a helpful treatment option for COVID-19.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.